COVID-19 vaccination in Kazakhstan

COVID-19 vaccination in Kazakhstan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Kazakhstan
Share of population in Kazakhstan that has received at least one dose of COVID-19 vaccine by region as of 29 July 2022
Date1 February 2021 (2021-02-01) – present
LocationKazakhstan
CauseCOVID-19 pandemic in Kazakhstan
Part of a series on the
COVID-19 pandemic
Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.
Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.
Timeline
2019
2020
2021
2022
2023
Locations
By country and territory
By conveyance
International response
National responses
Medical response
Vaccines
Current vaccines
Variants
Variants of concern
Other variants
Economic impact and recession
By country
By sport
Impacts
Society
virus icon COVID-19 portal

Background

Shortly after the COVID-19 outbreak in Kazakhstan, Erlan Ramanqūlov, the Director General of the National Center for Biotechnology announced in April 2020 the stages on developing the COVID-19 vaccine, acknowledging that clinical trials usually take up to 10 years to develop and that all verified research process would be cut short due to intense situation in the country, making the vaccine against coronavirus be produced usually faster and forecasted that it would be available to the public within next year and a half.[1]

On 18 May 2020, the Ministry of Education and Science announced that the preclinical trials for the local COVID-19 vaccine had begun of which was developed by the employees of the Research Institute of Biological Safety Problems of the Science Committee (BQPĞZÏ) under the Ministry by the strain of the coronavirus isolated from patients and that the World Health Organization (WHO) had registered the vaccine development.[2] At the cabinet meeting, Education and Science Minister Ashat Aimagambetov announced that five COVID-19 vaccines were being developed and that the preclinical trials would be tested on animals until September 2020, when the clinical stages would begin for humans.[3] In August 2020, the National Center for Expertise of Medicines and Medical Devices reported that the QazCovid-in vaccine showed no dangers during preclinical study stage and ruled that the testing could advance further into clinical trials on humans.[4] Starting 1 September 2020, the BQPĞZI began recruiting volunteers for conducting clinical trials of QazCovid-in.[5] In December 2020, the Ministry of Healthcare approved the final phase III of clinical trials by the BQPĞZI for 3,000 volunteers, by which the institute reported 96% efficiency rate of QazCovid-in.[6]

Kazakhstan has created its own COVID-19 vaccination, QazCovid-in, developed by the Research Institute for Biological Safety Problems.[7] On 7 April 2021, the Healthcare Minister Alexey Tsoi announced that the Kazakh government had requested 4 million doses of Russia's Sputnik V vaccine, in addition to 2 million doses already received earlier in 2021, as part of an ongoing vaccination programme alongside QazCovid-in.[8]

In October 2021, the first Kazakh vaccine to protect cats from COVID-19, NARUVAX-C19, was unveiled at the Kazagro/Kazfarm-2021 international exhibition.[9]

Vaccine in order
Vaccine Approval Deployment
Sputnik V Yes Yes
QazCovid-in Yes Yes
Sinopharm BIBP[10] Yes Yes
Sinovac[11] Yes Yes
Sputnik Light[12] Yes No
QazCoVac-P No No

Vaccination rate by region
Region Vaccinated population (as of 29 July 2022)[13]
Amount Percentage
1st dose 2nd dose Booster dose 1st dose 2nd dose Booster dose
Akmola Region 376,526 363,785 51.3% 49.6%
Aktobe Region 442,646 435,541 48.6% 47.8%
Almaty Region 1,183,805 1,130,834 55.9% 53.4%
Atyrau Region 292,152 276,467 43.4% 41.1%
East Kazakhstan Region 1,032,215 1,025,710 76.2% 75.7%
Jambyl Region 772,156 762,453 67.0% 66.1%
Karaganda Region 726,370 678,609 53.0% 49.5%
Kostanay Region 380,772 367,483 44.5% 42.9%
Kyzylorda Region 516,071 510,599 62.0% 61.4%
Mangystau Region 279,861 272,261 37.3% 36.3%
Pavlodar Region 385,060 375,954 51.6% 50.4%
North Kazakhstan Region 342,656 338,133 64.1% 63.3%
Turkistan Region 1,294,982 1,290,145 62.0% 61.8%
West Kazakhstan Region 297,268 287,561 44.5% 43.1%
Almaty 1,211,479 1,186,646 59.1% 57.9%
Nur-Sultan 542,653 516,130 43.0% 40.9%
Shymkent 707,126 696,298 62.9% 61.9%
 Kazakhstan 10,783,798 10,514,609 5,012,630 57.5% 56.1% 26.7%
Total doses: 26,311,037

References
  1. "Названы сроки создания вакцины против COVID-19 в Казахстане - Новости Казахстана и мира на сегодня". 24.kz (in Russian). April 17, 2020. Retrieved July 15, 2021.
  2. "В Казахстане начали доклинические испытания вакцины от коронавируса - Аналитический интернет-журнал Vласть". vlast.kz (in Russian). May 18, 2020. Archived from the original on May 26, 2020. Retrieved July 15, 2021.
  3. Дубовая, Мария (June 19, 2020). "Испытания казахстанской вакцины против коронавируса на людях планируют начать в сентябре". informburo.kz (in Russian). Archived from the original on July 24, 2020. Retrieved July 15, 2021.
  4. "Казахстанская вакцина от COVID-19 может быть применена на людях-добровольцах – НЦЭЛС". KazTAG (in Russian). August 19, 2020. Retrieved July 14, 2023.
  5. "THE RECEPTION OF QUESTIONNAIRES OF VOLUNTEERS TO PARTICIPATE IN CLINICAL TRIALS OF THE KAZAKHSTANI QAZCOVID-IN®-COVID-19 INACTIVATED VACCINE, DEVELOPED AT RIBSP HAS BEGUN" (Press release). Research Institute for Biological Safety Problems. September 1, 2020. Retrieved July 14, 2023.
  6. "Kazakhstan starts vaccination of three thousand volunteers with domestic QazCovid-in vaccine". primeminister.kz. December 19, 2020. Retrieved July 14, 2023.
  7. Yergaliyeva, Aidana (December 20, 2020). "Kazakhstan Begins Vaccinating 3,000 Volunteers With Self-Made QazCovid-in". The Astana Times. Archived from the original on December 28, 2020. Retrieved April 7, 2021.
  8. Reuters Staff (April 7, 2021). "Kazakhstan asks Russia for additional Sputnik V supplies". Reuters. Retrieved April 7, 2021. {{cite news}}: |author= has generic name (help)
  9. October 2021, Saniya Bulatkulova in Society on 25 (October 25, 2021). "No Pet Left Behind! New NARUVAX-C19 Vaccine for Cats Unveiled in Nur-Sultan". The Astana Times. Retrieved December 8, 2021.
  10. Satubaldina, Assel (April 30, 2021). "Three Vaccines to Become Available to Kazakh Citizens". The Astana Times. Archived from the original on April 30, 2021. Retrieved May 1, 2021.
  11. "В Казахстан доставили первую партию китайской вакцины CoronaVac | Kazakhstan Today". www.kt.kz (in Russian). Retrieved June 7, 2021.
  12. "Kazakhstan approves Russia's single-dose Sputnik Light vaccine". Reuters. Moscow. July 15, 2021. Retrieved July 15, 2021.
  13. "Информация о проведении вакцинации населения против КВИ на 29.07.2022 г. в разрезе регионов". gurk.kz (in Russian). МЕДИА-ЦЕНТР МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РК. July 29, 2022. Archived from the original on July 30, 2022. Retrieved July 30, 2022.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.